Clinical Trial Update: Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07) [Phase 3]

View source ↗

Summary

A Phase 3 long-term study evaluating the safety and efficacy of roflumilast in Japanese patients with bronchial asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: AstraZeneca | Conditions: Bronchial Asthma | Phase 3 | Status: COMPLETED